Lv1
40 积分 2025-05-21 加入
Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon
1个月前
已完结
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
1个月前
已完结
Variant screening of PYY 3–36 leads to potent long-acting PYY analogs with superior Y 2 receptor selectivity
1个月前
已完结
皖公网安备34019202002308
